UCB's Global Corporate Website
Welcome to UCB in the United States

Jun

13

UCB Builds Partnerships with Rare Epilepsy Syndrome Patient Groups

May

02

JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS)

Apr

01

UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting